Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-20T15:33:50.375Z Has data issue: false hasContentIssue false

Abrupt Withdrawal of Antiparkinsonian Drugs in Chronic Schizophrenic Patients

Published online by Cambridge University Press:  29 January 2018

H. A. McLelland
Affiliation:
St. Nicholas Hospital, Gosforth, Newcastle upon Tyne, NE3 3XT
G. Blessed
Affiliation:
St. Nicholas Hospital, Gosforth, Newcastle upon Tyne, NE3 3XT
S. Bhate
Affiliation:
St. Nicholas Hospital, Gosforth, Newcastle upon Tyne, NE3 3XT
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1974 

References

Chien, C., Dimascio, A. & Cole, J. O. (1974) Antiparkinsonian agents and depot phenothiazines. Amer. J. Psychiat., 131, 86–8.Google Scholar
El-Yousef, , Janowsky, D. S., Davies, J. M. & Sekerke, H. J. (1973) Reversal of antiparkinsonian drug toxicity by physostigmine. Amer. J. Psychiat., 130, 141–5.CrossRefGoogle ScholarPubMed
Fann, W. E., Lake, C. R., Gerber, C. J. & Mackenzie, J. M. (1974) Cholinergic suppression of tardive dyskinesia. Psychopharmacologia (Berl.), 37, 101107.Google Scholar
Gerlach, J., Reisby, N. & Randrup, A. (1974) Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.), 34, 31–5.Google Scholar
Klawans, H. L. (1973) The pharmacology of tardive dyskinesia. Amer. J. Psychiat., 130, 82–6.Google Scholar
Meyler, L. & Herxheimer, A. (1972) Side Effects of Drugs. Vol. vii. Amsterdam: Excerpta Medica.Google Scholar
Mindham, R. H. S., Gaind, R., Anstee, B. H. & Rimmer, L. (1972) Comparison of amantidine, orphenadrine and placebo in the control of phenothiazine-induced parkinsonism. Psychol. Med., 2, 406413.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.